Wrap Text
ASPI announces endowment of new Photonics Chair at Wits University to advance Photonics research
ASP ISOTOPES INC.
(Incorporated in the State of Delaware,
United States of America)
(Delaware file number 6228898)
Ticker Symbol: NASDAQ: ASPI
ISIN: US00218A1051
LEI: 6488WHV94BZ496OZ3219
JSE Share Code: ISO
("ASPI" or "the Company")
ASPI ANNOUNCES ENDOWMENT OF NEW PHOTONICS CHAIR AT WITS UNIVERSITY TO ADVANCE
PHOTONICS RESEARCH
WASHINGTON, Nov. 28, 2025 (GLOBE NEWSWIRE) -- ASP Isotopes Inc. (NASDAQ:) ("ASP Isotopes" or
the "Company"), an advanced materials company focused on developing technologies and processes for
the production of isotopes for multiple industries, today announced the establishment of a new Photonics
Chair at the University of Witwatersrand, Johannesburg (Wits University), through an endowment under a
three-year donation agreement. Dr. Angela Dudley has been named as the inaugural incumbent of the new
Photonics Chair.
The donation is expected to strengthen South Africa's photonics research capabilities by supporting the
pioneering work of the Structured Light Laboratory in Wits' School of Physics by:
1. Supporting the Structured Light Lab's cutting-edge photonics research and development;
2. Establishing a new Photonics Chair, with Dr. Angela Dudley at the helm, to drive excellence and
innovation in the field; and
3. Producing a pipeline of new students and candidates for ASP Isotopes.
"Our quantum enrichment programme, which is expanding rapidly from laboratory demonstrations to
production plants, requires both thought leaders who outline the future of the core technology, and a skilled
workforce. We believe that this new Chair will do exactly this: support fundamental research that is forward
looking while producing excellently trained young talent," commented Mr Robert Ainscow from ASP
Isotopes.
Prof. Nithaya Chetty, the Dean of the Faculty of Science, says: "Wits is making tremendous strides in
photonics and its applications, and this new Chair will undoubtedly advance Wits' research in this area. We
are proud to host the inaugural Photonics Chair at Wits and look forward to seeing the impact of this
partnership in society."
Serving as the inaugural Photonics Chair, Dr. Angela Dudley will lead research that translates fundamental
research in photonics into real-world applications. Internationally recognised for her work in structured light,
Dr. Dudley brings a distinguished record of research excellence, mentorship, and global collaboration to
the position.
"It is a tremendous honor to serve as the Photonics Chair at Wits," commented Dr. Angela Dudley. "ASPI's
commitment to advancing science provides the resources and partnerships needed to translate advanced
photonics concepts into technologies that can benefit South Africa and the world. I am extremely grateful
for ASPI's generosity and excited to support their work as we build a vibrant research programme and train
the next generation of photonics innovators."
Photonics – the science of generating and manipulating light – is transforming multiple sectors of society,
from improving medical diagnostics through advanced imaging and laser-based treatments to
strengthening communication networks with ultra-fast fibre optics. These technologies are driving
innovation across healthcare, telecommunications, manufacturing, security, renewable energy and
quantum computing.
Prof. Andrew Forbes, a trailblazer in this area from the Wits School of Physics, says: "This initiative fits
perfectly with our national quantum strategy – to work with industry to convert science into new economies.
This new Chair, together with the context of quantum enrichment by ASPI is a good example of how
quantum-inspired solutions can create a better tomorrow for all."
About ASP Isotopes:
ASP Isotopes Inc. is a development stage advanced materials company dedicated to the development of
technology and processes to produce isotopes for use in multiple industries. The Company employs
proprietary technology, the Aerodynamic Separation Process ("ASP technology"). The Company's initial
focus is on producing and commercializing highly enriched isotopes for the healthcare and technology
industries. The Company also plans to enrich isotopes for the nuclear energy sector using Quantum
Enrichment technology that the Company is developing. The Company has isotope enrichment facilities in
Pretoria, South Africa, dedicated to the enrichment of isotopes of elements with a low atomic mass (light
isotopes).
There is a growing demand for isotopes such as Silicon-28, which will enable quantum computing, and
Molybdenum-100, Molybdenum-98, Zinc-68, Ytterbium-176, and Nickel-64 for new, emerging healthcare
applications, as well as Chlorine-37, Lithium-6, and Uranium-235 for green energy applications. We believe
the ASP technology (Aerodynamic Separation Process) is ideal for enriching low and heavy atomic mass
molecules. For more information, please visit www.aspisotopes.com.
About the Structured Light Laboratory:
The Structured Light Laboratory (https://www.structured-light-lab.org/) at Wits University pioneers research
in controlling and shaping light for applications ranging from imaging and sensing to communications and
quantum technologies. The laboratory is recognised globally for its creative approaches to laser technology
and quantum optics with its contributions to both fundamental science and practical implementation.
About Wits University:
The University of the Witwatersrand (Wits University, https://www.wits.ac.za/) is renowned for over 100
years of academic and research excellence. As a leading African institution, Wits produces world-class
research that is locally relevant and globally competitive, fostering a vibrant intellectual community
dedicated to social impact and scientific discovery.
Contact:
Investor relations
ir@aspisotopes.com
The Company has a primary listing on the Nasdaq and a secondary listing on the Main Board of the JSE.
28 November 2025
Sponsor
Valeo Capital Proprietary Limited
Date: 28-11-2025 05:35:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
Sharenet Sites 
